|
GSK3368715 dihydrochloride
|
|
1628925-77-8
|
|
Ganoderic acid G
|
|
98665-22-6
|
|
GRGDSP
|
|
91037-75-1
|
|
GSM-1
|
|
884600-68-4
|
|
GNF-8625 monopyridin-N-piperazine hydrochloride
|
|
2412055-62-8
|
|
Glicoricone
|
|
161099-37-2
|
|
Gelsenicine
|
|
82354-38-9
|
|
GNE-6468
|
|
1677668-27-7
|
|
Ginsenoside Rs2
|
|
87733-66-2
|
|
GDC-0425
|
|
1200129-48-1
|
|
Glabrol
|
|
59870-65-4
|
|
Ganoderenic acid D
|
|
100665-43-8
|
|
GLP-1R modulator L7-028
|
|
2648317-95-5
|
|
Glabranine
|
|
41983-91-9
|
|
GSK-A1
|
|
1416334-69-4
|
|
GnRH antagonist 2
|
|
1709823-61-9
|
|
Gamitrinib TPP hexafluorophosphate
|
|
1131626-47-5
|
|
GSK598809
|
|
863680-45-9
|
|
GSK-3 inhibitor 1
|
|
603272-51-1
|
|
GSK-3β inhibitor 1
|
|
187325-53-7
|
|
GDC-0834 S-enantiomer
|
|
1133432-50-4
|
|
Galidesivir hydrochloride
|
|
222631-44-9
|
|
Ginsenoside Rd2
|
|
83480-64-2
|
|
Gelsevirine
|
|
38990-03-3
|
|
GSK2593074A
|
|
1337531-06-2
|
|
GNE-0439
|
|
1241902-40-8
|
|
GSK256066 Trifluoroacetate
|
|
1415560-64-3
|
|
Gigantol
|
|
67884-30-4
|
|
Ganoderenic acid E
|
|
110241-23-1
|
|
Givosiran
|
|
1639325-43-1
|
|
GSK8573
|
|
1693766-04-9
|
|
GLPG2938
|
|
2130996-00-6
|
|
(+)Gomisin M2
|
|
82425-45-4
|
|
GSK3-IN-3
|
|
331963-27-0
|
|
GNE-7915 tosylate
|
|
2070015-00-6
|
|
Glucocorticoid receptor agonist
|
|
1245526-82-2
|
|
Garcinone D
|
|
107390-08-9
|
|
GPR120 Agonist 3
|
|
1599477-75-4
|
|
Ginsenoside Rh4
|
|
174721-08-5
|
|
Ganoderic acid F
|
|
98665-15-7
|
|
Ginsenoside Rs1
|
|
87733-67-3
|
|
GNE 220 hydrochloride
|
|
2448286-21-1
|
|
GSK-3/CDK5/CDK2-IN-1
|
|
395074-72-3
|
|
Glucocorticoid receptor agonist-2
|
|
2166378-92-1
|
|
Ginsenoside Rk2
|
|
364779-14-6
|
|
Galegine hydrochloride
|
|
2368870-39-5
|
|
GSK3494245
|
|
2080410-41-7
|
|
Ginsenoside Ra2
|
|
83459-42-1
|
|
GNE-0946
|
|
1677667-24-1
|
|
(E/Z)-GSK-3β inhibitor 1
|
|
3367-88-2
|
|
G12
|
|
162550-82-5
|
|
Glucose dehydrogenase (GDH)
|
|
9028-53-9
|
|
GN25
|
|
1227401-27-5
|
|
Galantamine Hydrobromide Lycoremine
|
|
|
|
Glutaminase-IN-1
|
|
2247127-79-1
|
|
GSK-269984A
|
|
892664-04-9
|
|
Guaiacin
|
|
36531-08-5
|
|
8-Geranyl daidzein
|
|
1072940-16-9
|
|
20(R)-Ginsenoside Rg2
|
|
80952-72-3
|
|
GB1107
|
|
1978336-61-6
|
|
Gumelutamide
|
|
1831085-48-3
|
|
GNA002
|
|
1385035-79-9
|
|
Garsorasib
|
|
2559761-14-5
|
|
Gelucire 44/14
|
|
121548-04-7
|
|
(-)Gomisin L1
|
|
82425-43-2
|
|
GDC-0276
|
|
1494581-70-2
|
|
Giredestrant
|
|
1953133-47-5
|
|
GLP-26
|
|
2133017-36-2
|
|
GDP-α-D-mannose disodium
|
|
148296-46-2
|
|
Ginsenoside Ra1
|
|
83459-41-0
|
|
gamma-secretase modulator 1 hydrochloride
|
|
2741571-83-3
|
|
GalNac-L96
|
|
1159408-62-4
|
|
Ganodermanontriol
|
|
106518-63-2
|
|
GSK1820795A
|
|
2650253-86-2
|
|
GW-406381
|
|
221148-46-5
|
|
GW768505A free base
|
|
501693-25-0
|
|
Ginsenoside Ra3
|
|
90985-77-6
|
|
Gomisin G
|
|
62956-48-3
|
|
Glucocorticoid receptor agonist-2 Ala-Ala-Mal
|
|
2166376-64-1
|
|
GSK726701A
|
|
945721-87-9
|
|
Ginsenoside Rh8
|
|
343780-69-8
|
|
GSK 690 Hydrochloride
|
|
2436760-79-9
|
|
GPR40 Activator 2
|
|
1312787-30-6
|
|
GDC-0575 dihydrochloride
|
|
1657014-42-0
|
|
Glucosylceramide synthase-IN-2
|
|
2597958-02-4
|
|
Ganolactone A
|
|
173268-82-1
|
|
20-gluco-ginsenoside Rf
|
|
68406-27-9
|
|
GSK-3685032
|
|
2170137-61-6
|
|
Glycolithocholic acid 3-sulfate
|
|
15324-64-8
|
|
GSK2245035
|
|
1207629-49-9
|
|
Glycolic acid-d2
|
|
75502-10-2
|
|
GPR40 Activator 1
|
|
1309435-60-6
|
|
Glycoside O-4
|
|
94898-61-0
|
|
Ginsenoside F5
|
|
189513-26-6
|
|
Ginsenoside Ra6
|
|
1346522-89-1
|
|
Gensenoside Rh7
|
|
343780-68-7
|
|
Gartanin
|
|
33390-42-0
|
|
Gefitinib impurity 2
|
|
246512-44-7
|
|
GSK-872 hydrochloride
|
|
2703752-81-0
|
|
Glyco-diosgenin
|
|
1402423-29-3
|